# Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis

> **NCT02873468** · PHASE2 · UNKNOWN · sponsor: **EMS** · enrollment: 116 (estimated)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Florence 30 μg/mL
- **DRUG:** Florence 60 μg/mL
- **DRUG:** Florence 90 μg/mL
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02873468
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-19
- **Primary completion:** 2025-07
- **Final completion:** 2025-11
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2023-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02873468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02873468, "Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02873468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*